# C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck

> **NCT00402545** · PHASE1 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 29 (estimated)

## Conditions studied

- Head and Neck Neoplasms

## Interventions

- **DRUG:** Cetuximab
- **DRUG:** Docetaxel
- **DRUG:** Cisplatin
- **DRUG:** 5-Fluorouracil

## Key facts

- **NCT ID:** NCT00402545
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2009-11-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00402545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00402545, "C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00402545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*